Aghajanian, Haig http://orcid.org/0000-0002-8317-0157
Rurik, Joel G. http://orcid.org/0000-0002-7156-4626
Epstein, Jonathan A. http://orcid.org/0000-0001-8637-4465
Funding for this research was provided by:
Fondation Leducq
Article History
Received: 21 September 2021
Accepted: 20 January 2022
First Online: 28 February 2022
Competing interests
: H.A. and J.A.E. are cofounders and hold equity in Capstan Therapeutics, which develops therapeutics to reprogramme immune cells in vivo. At present, H.A. serves in a management role with Capstan Therapeutics. J.G.R. declares no competing interests.
Free to read: This content has been made available to all.